Literature DB >> 19666466

Characterization of the human sulfatase Sulf1 and its high affinity heparin/heparan sulfate interaction domain.

Marc-André Frese1, Fabian Milz, Marina Dick, William C Lamanna, Thomas Dierks.   

Abstract

The extracellular sulfatases Sulf1 and Sulf2 remodel the 6O-sulfation state of heparan sulfate proteoglycans on the cell surface, thereby modulating growth factor signaling. Different from all other sulfatases, the Sulfs contain a unique, positively charged hydrophilic domain (HD) of about 320 amino acid residues. Using various HD deletion mutants and glutathione S-transferase (GST)-HD fusion proteins, this study demonstrates that the HD is required for enzymatic activity and acts as a high affinity heparin/heparan sulfate interaction domain. Association of the HD with the cell surface is sensitive to heparinase treatment, underlining specificity toward heparan sulfate chains. Correspondingly, isolated GST-HD binds strongly to both heparin and heparan sulfate in vitro and also to living cells. Surface plasmon resonance studies indicate nanomolar affinity of GST-HD toward immobilized heparin. The comparison of different mutants reveals that especially the outer regions of the HD mediate heparan sulfate binding, probably involving "tandem" interactions. Interestingly, binding to heparan sulfate depends on the presence of 6O-sulfate substrate groups, suggesting that substrate turnover facilitates release of the enzyme from its substrate. Deletion of the inner, less conserved region of the HD drastically increases Sulf1 secretion without affecting enzymatic activity or substrate specificity, thus providing a tool for the in vitro modulation of HS-dependent signaling as demonstrated here for the signal transduction of fibroblast growth factor 2. Taken together, the present study shows that specific regions of the HD influence different aspects of HS binding, cellular localization, and enzyme function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19666466      PMCID: PMC2788855          DOI: 10.1074/jbc.M109.035808

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

Review 1.  Functions of cell surface heparan sulfate proteoglycans.

Authors:  M Bernfield; M Götte; P W Park; O Reizes; M L Fitzgerald; J Lincecum; M Zako
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

2.  Regulation of Wnt signaling and embryo patterning by an extracellular sulfatase.

Authors:  G K Dhoot; M K Gustafsson; X Ai; W Sun; D M Standiford; C P Emerson
Journal:  Science       Date:  2001-08-31       Impact factor: 47.728

Review 3.  The affinity of fibroblast growth factors (FGFs) for heparin; FGF-heparan sulfate interactions in cells and extracellular matrix.

Authors:  M Klagsbrun
Journal:  Curr Opin Cell Biol       Date:  1990-10       Impact factor: 8.382

4.  A modular set of prokaryotic and eukaryotic expression vectors.

Authors:  K Melcher
Journal:  Anal Biochem       Date:  2000-01-01       Impact factor: 3.365

5.  Zinc ions promote the interaction between heparin and heparin cofactor II.

Authors:  Ralf Eckert; Hermann Ragg
Journal:  FEBS Lett       Date:  2003-04-24       Impact factor: 4.124

6.  The molecular phenotype of heparan sulfate in the Hs2st-/- mutant mouse.

Authors:  C L Merry; S L Bullock; D C Swan; A C Backen; M Lyon; R S Beddington; V A Wilson; J T Gallagher
Journal:  J Biol Chem       Date:  2001-07-16       Impact factor: 5.157

7.  Protein-heparin interactions measured by BIAcore 2000 are affected by the method of heparin immobilization.

Authors:  Ronald I W Osmond; Warren C Kett; Spencer E Skett; Deirdre R Coombe
Journal:  Anal Biochem       Date:  2002-11-15       Impact factor: 3.365

8.  Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin.

Authors:  L Pellegrini; D F Burke; F von Delft; B Mulloy; T L Blundell
Journal:  Nature       Date:  2000-10-26       Impact factor: 49.962

9.  Cloning and characterization of two extracellular heparin-degrading endosulfatases in mice and humans.

Authors:  Megumi Morimoto-Tomita; Kenji Uchimura; Zena Werb; Stefan Hemmerich; Steven D Rosen
Journal:  J Biol Chem       Date:  2002-10-03       Impact factor: 5.157

10.  Differential involvement of the extracellular 6-O-endosulfatases Sulf1 and Sulf2 in brain development and neuronal and behavioural plasticity.

Authors:  Ina Kalus; Benedikt Salmen; Christoph Viebahn; Kurt von Figura; Dietmar Schmitz; Rudi D'Hooge; Thomas Dierks
Journal:  J Cell Mol Med       Date:  2009 Nov-Dec       Impact factor: 5.310

View more
  32 in total

1.  Glucosamine-6-sulfamate analogues of heparan sulfate as inhibitors of endosulfatases.

Authors:  Mathias Schelwies; Diana Brinson; Shuhei Otsuki; Young-Hoon Hong; Martin K Lotz; Chi-Huey Wong; Sarah R Hanson
Journal:  Chembiochem       Date:  2010-11-22       Impact factor: 3.164

2.  Pectin from Prunus domestica L. induces proliferation of IEC-6 cells through the alteration of cell-surface heparan sulfate on differentiated Caco-2 cells in co-culture.

Authors:  Mitsutaka Nishida; Kazuma Murata; Kazuya Oshima; Chihiro Itoh; Kohji Kitaguchi; Yoshihiro Kanamaru; Tomio Yabe
Journal:  Glycoconj J       Date:  2015-04-23       Impact factor: 2.916

3.  Type 2 diabetes in mice induces hepatic overexpression of sulfatase 2, a novel factor that suppresses uptake of remnant lipoproteins.

Authors:  Keyang Chen; Ming-Lin Liu; Lana Schaffer; Mingzhen Li; Guenther Boden; Xiangdong Wu; Kevin Jon Williams
Journal:  Hepatology       Date:  2010-11-03       Impact factor: 17.425

Review 4.  Interactions of signaling proteins, growth factors and other proteins with heparan sulfate: mechanisms and mysteries.

Authors:  Paul C Billings; Maurizio Pacifici
Journal:  Connect Tissue Res       Date:  2015       Impact factor: 3.417

Review 5.  Sulf-2: an extracellular modulator of cell signaling and a cancer target candidate.

Authors:  Steven D Rosen; Hassan Lemjabbar-Alaoui
Journal:  Expert Opin Ther Targets       Date:  2010-09       Impact factor: 6.902

6.  Sulfatases are determinants of alveolar formation.

Authors:  Emilio Arteaga-Solis; Carmine Settembre; Andrea Ballabio; Gerard Karsenty
Journal:  Matrix Biol       Date:  2012-02-18       Impact factor: 11.583

7.  Recapitulation of pharmacogenomic data reveals that invalidation of SULF2 enhance sorafenib susceptibility in liver cancer.

Authors:  Sarah Yoon; Eun-Ju Lee; Ji-Hye Choi; Taek Chung; Do Young Kim; Jong-Yeop Im; Myung-Ho Bae; Jung-Hee Kwon; Hyuk-Hoon Kim; Hyung Chul Kim; Young Nyun Park; Hee-Jung Wang; Hyun Goo Woo
Journal:  Oncogene       Date:  2018-05-03       Impact factor: 9.867

8.  Organ-specific sulfation patterns of heparan sulfate generated by extracellular sulfatases Sulf1 and Sulf2 in mice.

Authors:  Satoshi Nagamine; Michiko Tamba; Hisako Ishimine; Kota Araki; Kensuke Shiomi; Takuya Okada; Tatsuyuki Ohto; Satoshi Kunita; Satoru Takahashi; Ronnie G P Wismans; Toin H van Kuppevelt; Masayuki Masu; Kazuko Keino-Masu
Journal:  J Biol Chem       Date:  2012-02-01       Impact factor: 5.157

9.  Human Sulfatase 2 inhibits in vivo tumor growth of MDA-MB-231 human breast cancer xenografts.

Authors:  Sarah M Peterson; Andrea Iskenderian; Lynette Cook; Alla Romashko; Kristen Tobin; Michael Jones; Angela Norton; Alicia Gómez-Yafal; Michael W Heartlein; Michael F Concino; Lucy Liaw; Paolo G V Martini
Journal:  BMC Cancer       Date:  2010-08-13       Impact factor: 4.430

10.  Heparan sulfation is essential for the prevention of cellular senescence.

Authors:  S H Jung; H C Lee; D-M Yu; B C Kim; S M Park; Y-S Lee; H J Park; Y-G Ko; J-S Lee
Journal:  Cell Death Differ       Date:  2015-08-07       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.